Filter
199
Filtered Results: 199
Text search:
Bedaquiline
Featured
Recommendations
34
New Publications
54
Language
Document type
No document type
123
Guidelines
27
Studies & Reports
23
Manuals
10
Strategic & Response Plan
5
Fact sheets
5
Training Material
3
Situation Updates
3
Countries / Regions
Western and Central Europe
20
Eastern Europe
16
India
12
Global
5
Germany
4
South Africa
4
Asia
3
Uganda
3
Ethiopia
3
El Salvador
2
Latin America and the Carribbean
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Bolivia
2
Argentina
2
Russia
2
Nepal
1
Kenya
1
Ukraine
1
Nigeria
1
Estonia
1
Malawi
1
Philippines
1
Dominican Republic
1
Paraguay
1
Bangladesh
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
Countries
46
Clinical Guidelines
39
Public Health
3
Key Resources
2
Pharmacy & Technologies
2
Toolboxes
TB
146
HIV
7
Pharmacy
5
NTDs
4
AMR
4
Caregiver
3
Health Financing Toolbox
3
Polio
3
Refugee
2
COVID-19
2
Conflict
1
Global Health Education
1
Policy framework.
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon...
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
To meet our Strategy objectives and get within reach
of the 2030 SDG 3 target related to the three diseases,
the Global Fund needs to raise US$18 billion for the
Eighth Replenishment. That sum is essential to drive the
required pace of progress in the fight against HIV, TB
and malaria, and to m...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Los presentes Lineamientos tecnicos del ministerio de salud de El Salvador establece las disposiciones para la prevención y control de la tuberculosis, para su aplicación por el personal del Sistema Nacional Integrado de Salud para incidir en la reducción de la morbimortalidad causada por la enfe...
Clinical guidelines for the comprehensive care of patients with drug-resistant tuberculosis
Serie: Documentos Técnico normativos
Serie: Documentos Técnico normativos
Rev Mex Patol Clin Med Lab 2020; 67 (2): 93-112: La tuberculosis (TB) es en la actualidad la patología de tipo infeccioso que causa mayor número de muertes alrededor del mundo cada año. La percepción acerca de esta entidad ha cambiado a lo largo del tiempo, ya que se consideraba que se relaciona...
